奥佳华(002614) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥1,357,845,848.98, a decrease of 13.49% year-on-year[7] - Net profit attributable to shareholders was ¥101,263,732.02, down 38.64% compared to the same period last year[7] - Basic earnings per share decreased by 40.00% to ¥0.18[7] - The company's total profit for the current period is ¥220,810,826.96, down 42.5% from ¥385,137,848.93 in the previous period[54] - Net profit for Q3 2019 was CNY 106,809,869.61, a decline of 35.7% from CNY 166,347,437.07 in Q3 2018[47] - The net profit for the current period is CNY 140,457,089.69, down 49.3% from CNY 277,117,364.45 in the same period last year[57] Cash Flow - The net cash flow from operating activities was ¥77,666,710.36, a significant increase of 5,321.96% compared to the previous period[7] - The company's cash flow from operating activities showed a net outflow of ¥147,370,461.37, a decrease of 226.30% compared to the same period last year[22] - The total cash inflow from operating activities is CNY 4,093,903,447.69, an increase of 12.87% compared to CNY 3,628,394,520.90 in the previous period[62] - Net cash flow from operating activities was -CNY 767,532,656.83, worsening from -CNY 407,998,015.39 year-over-year[64] Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,023,559,154.63, an increase of 1.04% compared to the end of the previous year[7] - The company's total liabilities stood at RMB 2,698,753,800.21, compared to RMB 2,658,828,545.42, marking an increase of about 1.5%[38] - The company's total liabilities related to trading financial liabilities surged by 1251.24% to ¥24,485,338.09, influenced by hedging activities[17] - Total current liabilities were CNY 2,571,702,451.26, unchanged from the previous period[70] Investments and Capital - The company completed a share buyback of 7,249,748 shares, accounting for 1.29% of the total share capital, with a total payment of ¥100.03 million[24] - The company has long-term investments amounting to CNY 1,029,963,691.14, reflecting its commitment to growth and expansion[73] - The company received CNY 620,000,000.00 from investment recoveries, an increase from CNY 494,000,000.00 in the previous period[64] Research and Development - Research and development expenses increased to CNY 62,687,586.67, compared to CNY 45,254,337.71 in Q3 2018, reflecting a focus on innovation[45] - Research and development expenses for the current period are ¥178,872,391.14, up 25.1% from ¥142,992,162.72 in the previous period[54] Market and Expansion - The company is accelerating overseas factory construction, with the Philippines factory operational since August and the Malaysia factory expected to start production in December[7] - The company aims to expand its product innovation and explore business opportunities in emerging global markets[7] - The company plans to continue focusing on market expansion and new product development to drive future growth[50] Financial Health - The weighted average return on net assets was 3.05%, down 2.35% from the previous year[7] - The company's financial expenses decreased by 92.84% to -¥29,459,199.62, mainly due to exchange rate fluctuations impacting financial costs[19] - The company's income tax expenses decreased by 80.23% to ¥13,967,291.90, primarily due to reduced land income and increased deferred tax provisions[20] Shareholder Information - The total number of shareholders at the end of the reporting period was 24,098[13] - The equity attributable to shareholders of the parent company was RMB 3,256,572,776.36, slightly up from RMB 3,244,843,064.02[39] Miscellaneous - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[30] - There were no instances of entrusted wealth management reported during the period[31] - The company conducted multiple institutional research activities throughout the quarter, indicating ongoing engagement with investors[32]